205 related articles for article (PubMed ID: 29324339)
1. Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine "bio-oxidizable" prodrugs: Synthesis, biological evaluation and structure-activity relationship.
Azzouz R; Peauger L; Gembus V; Ţînţaş ML; Sopková-de Oliveira Santos J; Papamicaël C; Levacher V
Eur J Med Chem; 2018 Feb; 145():165-190. PubMed ID: 29324339
[TBL] [Abstract][Full Text] [Related]
2. Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation.
Peauger L; Azzouz R; Gembus V; Ţînţaş ML; Sopková-de Oliveira Santos J; Bohn P; Papamicaël C; Levacher V
J Med Chem; 2017 Jul; 60(13):5909-5926. PubMed ID: 28613859
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
[TBL] [Abstract][Full Text] [Related]
4. Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studies.
Ţînţaş ML; Gembus V; Alix F; Barré A; Coadou G; Truong L; Sebban M; Papamicaël C; Oulyadi H; Levacher V
Eur J Med Chem; 2018 Jul; 155():171-182. PubMed ID: 29886321
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors.
Mostofi M; Mohammadi Ziarani G; Mahdavi M; Moradi A; Nadri H; Emami S; Alinezhad H; Foroumadi A; Shafiee A
Eur J Med Chem; 2015 Oct; 103():361-9. PubMed ID: 26363872
[TBL] [Abstract][Full Text] [Related]
6. Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors.
Baharloo F; Moslemin MH; Nadri H; Asadipour A; Mahdavi M; Emami S; Firoozpour L; Mohebat R; Shafiee A; Foroumadi A
Eur J Med Chem; 2015 Mar; 93():196-201. PubMed ID: 25681712
[TBL] [Abstract][Full Text] [Related]
7. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T
Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
[TBL] [Abstract][Full Text] [Related]
10. Indolinone-based acetylcholinesterase inhibitors: synthesis, biological activity and molecular modeling.
Akrami H; Mirjalili BF; Khoobi M; Nadri H; Moradi A; Sakhteman A; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Sep; 84():375-81. PubMed ID: 25036795
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of 2,3-dihydro-5,6-dimethoxy-1H-inden-1-one and piperazinium salt hybrid derivatives as hAChE and hBuChE enzyme inhibitors.
Mozaffarnia S; Teimuri-Mofrad R; Rashidi MR
Eur J Med Chem; 2020 Apr; 191():112140. PubMed ID: 32088494
[TBL] [Abstract][Full Text] [Related]
12. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new N-benzylpyridinium-based benzoheterocycles as potential anti-Alzheimer's agents.
Salehi N; Mirjalili BBF; Nadri H; Abdolahi Z; Forootanfar H; Samzadeh-Kermani A; Küçükkılınç TT; Ayazgok B; Emami S; Haririan I; Sharifzadeh M; Foroumadi A; Khoobi M
Bioorg Chem; 2019 Mar; 83():559-568. PubMed ID: 30471578
[TBL] [Abstract][Full Text] [Related]
14. Rational design of central selective acetylcholinesterase inhibitors by means of a "bio-oxidisable prodrug" strategy.
Bohn P; Le Fur N; Hagues G; Costentin J; Torquet N; Papamicaël C; Marsais F; Levacher V
Org Biomol Chem; 2009 Jun; 7(12):2612-8. PubMed ID: 19503937
[TBL] [Abstract][Full Text] [Related]
15. Dihydroquinoline Carbamate Derivatives as "Bio-oxidizable" Prodrugs for Brain Delivery of Acetylcholinesterase Inhibitors: [¹¹C] Radiosynthesis and Biological Evaluation.
Bohn P; Gourand F; Papamicaël C; Ibazizène M; Dhilly M; Gembus V; Alix F; Ţînţaş ML; Marsais F; Barré L; Levacher V
ACS Chem Neurosci; 2015 May; 6(5):737-44. PubMed ID: 25695305
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and In Vitro Biological Activities of a Bio-Oxidizable Prodrug to Deliver Both ChEs and DYRK1A Inhibitors for AD Therapy.
Barré A; Azzouz R; Gembus V; Papamicaël C; Levacher V
Molecules; 2019 Apr; 24(7):. PubMed ID: 30939771
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of edaravone derivatives bearing the
Zondagh LS; Malan SF; Joubert J
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1596-1605. PubMed ID: 32779503
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
[TBL] [Abstract][Full Text] [Related]
19. Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents.
Saeedi M; Golipoor M; Mahdavi M; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A
Arch Pharm (Weinheim); 2016 Apr; 349(4):293-301. PubMed ID: 26898241
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Evaluation of Chroman-4-One Linked to N-Benzyl Pyridinium Derivatives as New Acetylcholinesterase Inhibitors.
Arab S; Sadat-Ebrahimi SE; Mohammadi-Khanaposhtani M; Moradi A; Nadri H; Mahdavi M; Moghimi S; Asadi M; Firoozpour L; Pirali-Hamedani M; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2015 Sep; 348(9):643-9. PubMed ID: 26192069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
